NPI | Name | Type | Address |
---|---|---|---|
Laura Erlewine |
Individual |
505 Ne 87th Ave Suite 320 Vancouver, WA |
|
PHARMD Sharleen Huon |
Individual |
1708 Yakima Ave Suite 203 Tacoma, WA |
|
MS. RPH Gayla Dawn Curl |
Individual |
211 Nw 131st St Vancouver, WA |
|
PHARMD Eno Inyang |
Individual |
1717 S J St Ms 01-79 Tacoma, WA |
|
PHARMD Amy Ly Indorf |
Individual |
825 Eastlake Ave E #msg5-90 Seattle, WA |
|
PHARMD Alan Chin |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARMD Lien Thibich Do |
Individual |
3915 Talbot Rd S Ste 300 Renton, WA |
|
PHARMD Melissa Ferguson |
Individual |
820 N Chelan Ave Wenatchee, WA |
|
PHARM. D Sarah Schiavone |
Individual |
Silverdale Medical Center 10452 Silverdale Way Nw Silverdale, WA |
|
MRS. RPH Shawna Fletcher |
Individual |
310 S Roosevelt Ave Goldendale, WA |
|
PHARMD Kathryn Trieselmann |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARMD Truc Thanh Nguyen |
Individual |
4525 3rd Ave Se Ste 200 Olympia, WA |
|
MR. RPH Ryan Milo Glover |
Individual |
3700 Pacific Highway East Suite 100 Fife, WA |
|
Zakary Cerminara |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARMD Sydney Lee Smith |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARMD Deeter Ryan Neumann |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARMD Gordon Baldwin |
Individual |
401 15th Ave Se Puyallup, WA |
|
PHARMD Miryoung Kim |
Individual |
University Of Washington Medical Center Attn: Pharmacy 1959 Ne Pacific Street Seattle, WA |
|
PHARMD Dane Fritzsche |
Individual |
1354 Aloha St. Seattle, WA |
|
DR. PHARMD Andrew Thomas Ruplin |
Individual |
825 Eastlake Ave E Seattle, WA |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |